You searched for prescription-drugs | Page 52 of 178

Anti-Vaccine Disinformation Campaign, Sunscreen Myths, and Counterfeit Ozempic on Social Media — The Monitor

Jul 11, 2024

Feature

This edition focuses on intentionally false or misleading information online and its potential impact on public trust in health care. We share a recent report that exposed a covert U.S. military social media disinformation campaign in the Philippines that may have undermined public confidence in vaccines. We also examine how false claims about sunscreen and non-FDA-approved "miracle cures" may be discouraging people from taking important preventative measures and seeking legitimate medical treatment. Finally, we explore…

JAMA Infographic Prescription Drug Policy

Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs

Oct 15, 2019

Feature

US Public’s Opinion of Prescription Drug Costs Download VIEW JAMA INFOGRAPHIC

Why Drug Price Negotiation Has Staying Power

Jun 25, 2021

From Drew Altman

In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.

This chart shows the 14.5% premium increase is among the largest in program history.

Monthly Part B Premiums and Annual Percentage Increases

Jan 12, 2022

Feature

The $21.60 increase in 2022 is the largest in dollar terms since the start of the program, even though premiums have risen faster in percentage terms on three other occasions in the last 20 years

Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs

Oct 15, 2019

News Release

This Visualizing Health Policy infographic examines public opinion on prescription drug costs in the United States (US). Over the past 20 years, US drug spending has increased by 330% compared to a 208% increase in total US health expenditures. A large majority (78%) of the public see drug company profits as the top contributor to higher health care spending. Lowering drug costs is the public’s top health policy priority for the US Congress. While most…

DMPA Contraceptive Injection: Use and Coverage

May 30, 2024

Fact Sheet

This factsheet provides an overview of the types of contraceptive injection, use, awareness, availability, and insurance coverage of the injection in the U.S.

Medicare Part D: A First Look at Prescription Drug Plans in 2020

Nov 14, 2019

Issue Brief

This issue brief provides an overview of the Medicare Part D prescription drug benefit plan landscape for 2020, with a focus on stand-alone drug plans, the largest segment of the Part D market. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D plans available in 2020.

New KFF Brief Takes a Closer Look at “Tele-PrEP” and the Future of PrEP Services in the United States

May 3, 2022

News Release

In 2020, only 25% of people who could benefit from pre-exposure prophylaxis (PrEP), a medication that reduces the risk of acquiring HIV, were prescribed it. Using telehealth to provide PrEP, “tele-PrEP,” is a new approach that shows potential for expanding access to PrEP use in the United States that predates the COVID-19 pandemic. A new KFF analysis takes a deep dive into the tele-PrEP landscape, from the types of providers offering the service to the…

Annual Survey of Medicaid Directors Finds States Continue to Adopt Policies to Respond to the Pandemic and Are Addressing Issues Related to Social Determinants of Health and Health Equity

Oct 27, 2021

News Release

More than 18 months into the COVID-19 pandemic, state Medicaid programs around the country continue to reshape policy in response to the public health emergency and at the same time advance broader initiatives and priorities, including efforts to address the social determinants of health and health equity, finds a new KFF survey. The 21st annual KFF survey of Medicaid directors in states and the District of Columbia highlights policies in place and changes implemented or…

Implications of the Lapse in Federal COVID-19 Funding on Access to COVID-19 Testing, Treatment, and Vaccines

Mar 28, 2022

Issue Brief

A current impasse in Congress threatens continued funding for COVID-19 testing, treatment, and vaccines. The lack of additional federal COVID-19 funding has broad implications for access to these services, particularly for the uninsured, and could undermine efforts to ensure equitable access to these resources.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter